Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Dupuytren Contracture 2

Interventions

Cyclophosphamide 908Carboplatin 785Paclitaxel 739pembrolizumab 738Cisplatin 707Bevacizumab 705Gemcitabine 619Docetaxel 578Rituximab 548Radiotherapy 539Dexamethasone 510Nivolumab 485Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 357Pemetrexed 334Cytarabine 334Oxaliplatin 333Lenalidomide 327Prednisone 326fludarabine phosphate 315Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Has results × Collagenases × Clear all
NCT02725528 2023-07-18

EXTEND

McMaster University

Phase 3 Completed
22 enrolled 15 charts

Dupuytren Contracture

NCT01450397 2017-04-17

MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex

Hospital for Special Surgery, New York

Phase 4 Completed
5 enrolled 5 charts

Dupuytren Contracture

Data powered by HemOnc (CC BY 4.0) Colophon âš¡